Brief: Aroa Biosurgery Anticipates H2 FY25 Total Revenue Of NZ$43-$50 Million
25/11/2024 21:49
Nov 26 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* ANTICIPATES H2 FY25 TOTAL REVENUE OF NZ$43-$50 MILLION
* EXPECTS H2 FY24 NORMALISED EBITDA PROFIT OF NZ$4-8 MLN
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million